A
Anna Phillips-Waller
Researcher at Queen Mary University of London
Publications - 14
Citations - 1249
Anna Phillips-Waller is an academic researcher from Queen Mary University of London. The author has contributed to research in topics: Smoking cessation & Nicotine replacement therapy. The author has an hindex of 7, co-authored 13 publications receiving 829 citations.
Papers
More filters
Journal ArticleDOI
A randomized trial of E-cigarettes versus nicotine-replacement therapy
Peter Hajek,Anna Phillips-Waller,Dunja Przulj,Francesca Pesola,Katie Myers Smith,Natalie Bisal,Jinshuo Li,Steve Parrott,Peter Sasieni,Lynne Dawkins,Louise Ross,Maciej L. Goniewicz,Qi Wu,Hayden McRobbie +13 more
TL;DR: E‐cigarettes were more effective for smoking cessation than nicotine‐replacement therapy, when both products were accompanied by behavioral support.
Journal ArticleDOI
Nicotine delivery and users’ reactions to Juul compared with cigarettes and other e-cigarette products
Peter Hajek,Kate Pittaccio,Francesca Pesola,Katie Myers Smith,Anna Phillips-Waller,Dunja Przulj +5 more
TL;DR: Juul's PK profile and user ratings suggest that it could be more effective than other EC products in helping smokers to quit smoking, but it may also have a higher potential to generate regular use in non‐smokers.
Journal ArticleDOI
E-cigarettes compared with nicotine replacement therapy within the UK Stop Smoking Services: the TEC RCT.
Peter Hajek,Anna Phillips-Waller,Dunja Przulj,Francesca Pesola,Katie Myers Smith,Natalie Bisal,Jinshuo Li,Steve Parrott,Peter Sasieni,Lynne Dawkins,Louise Ross,Maciej L. Goniewicz,Qi Wu,Hayden McRobbie +13 more
TL;DR: Within the context of multisession treatment for smokers seeking help, e-cigarettes were significantly more effective than NRT and if SSSs provide e-cigarette starter packs, it is likely to boost their success rates and improve their cost-efficacy.
Journal ArticleDOI
Cost‐effectiveness of e‐cigarettes compared with nicotine replacement therapy in stop smoking services in England (TEC study): a randomized controlled trial
Jinshuo Li,Peter Hajek,Francesca Pesola,Qi Wu,Anna Phillips-Waller,Dunja Przulj,Katie Myers Smith,Natalie Bisal,Peter Sasieni,Lynne Dawkins,Louise Ross,Maciej L. Goniewicz,Hayden McRobbie,Steve Parrott +13 more
TL;DR: Using e‐cigarettes as a smoking cessation aid with standard behavioural support in stop‐smoking services in England is likely to be more cost‐effective than using nicotine replacement therapy in the same setting.
Journal ArticleDOI
Nicotine delivery and user reactions to Juul EU (20 mg/ml) compared with Juul US (59 mg/ml), cigarettes and other e-cigarette products.
TL;DR: Juul EU delivers much less nicotine to users than Juul US, and also less than refillable EC products, which means it may have more limited potential to help smokers quit.